Table 5.
Referral centres | Non-referral centres | P-value | |
---|---|---|---|
Newly diagnosed patients, n (%) | 45 (35) | 84 (65) | |
Delay between admission and diagnosis, median (IQR), days | 4 (2–13) | 7 (4–11) | 0.4 |
Delay between diagnosis and starting immunosuppression, median (IQR), days | 4 (3–10) | 9 (3–19) | 0.01 |
Patients treated with CYC, n (%) | 42 (32) | 88 (68) | |
Correct dose of i.v. CYC | 23/32 (72) | 29/57 (51) | 0.05 |
Admission with infection during or within 6 months of CYC therapy, n (%) | 9 (21) | 24 (27) | 0.5 |
Patients treated with RTX, n (%) | 48 (63) | 28 (37) | |
Co-prescription of PJP prophylaxis, % | 73 | 52 | 0.07 |